首页|早期保护肠屏障功能对重症胰腺炎患者的影响

早期保护肠屏障功能对重症胰腺炎患者的影响

扫码查看
目的:探讨早期保护肠屏障功能对重症急性胰腺炎(SAP)的影响。方法将2010年1月-2012年12月我院SAP患者120例分为两组,对照组55例采用常规疗法,观察组65例在此基础上实施肠屏障保护措施。比较两组干预后胃肠功能评分和APACHEⅡ评分、L/M水平、CRP和TNF-α水平,以及预后情况。结果观察组治疗后3、5、7d的胃肠功能评分、APACHEⅡ评分、L/M均低于对照组(P <0.05);治疗7d后内毒素低于对照组(P <0.05);两组CRP、TNF-α水平均呈先升后降趋势,观察组治疗3、5、7d的CRP、TNF-α水平低于对照组(P <0.05);观察组预后不良发生率明显低于对照组(P <0.05)。结论早期实施肠屏障保护措施有利于SAP胃肠功能的恢复,降低肠黏膜通透性及控制全身和局部的炎性反应。
Influence of intestinal barrier function in early protection on the patients with severe acute pancreatitis
Objective To explore the effect treatment of early protection of intestinal barrier function in the SAP. Methods 120 SAP patients were selected from January 2010 to December 2012 in our hospital, and were divided into the observation group with 65 cases and control group with 55 cases, the control group with conventional therapy, the implementation of intestinal barrier protective measures on the basis of the observation group. Comparison of gastrointestinal function score and APACHE Ⅱ score, endotoxin and urine lactulose/mannitol value level of L/M, CRP and TNF-α level, and prognosis of two groups after intervention. Results After treatment 3, 5, 7 days of gastrointestinal function score, APACHE score, L/M of the observation group were lower than the control group, lower than that of the control group(P <0.05); after 7 days of therapy of endotoxin was lower than the control group(P <0.05);CRP, TNF-α levels of the two groups were increased first and then decreased, after treatment 3, 5, 7 days, the CRP, TNF-α levels of observation group were lower than the control group(P <0.05);The incidence of adverse prognosis of observation group were significantly lower than the control group(P <0.05). Conclusion Early intestinal barrier protective measures are conducive to recovery of gastrointestinal function, reduce intestinal permeability and control of systemic and topical inflammatory reaction.

SAPGastrointestinal functionIntestinal barrier

钟科

展开 >

610500 成都医学院第一附属医院普外科

SAP 胃肠功能 肠屏障

2013

中国医疗前沿
中国医院协会

中国医疗前沿

影响因子:0.186
ISSN:1673-5552
年,卷(期):2013.(24)
  • 3